nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—gall bladder—liver cancer	0.0204	0.235	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—liver cancer	0.0145	1	CrCbGaD
Hydroxocobalamin—MUT—gall bladder—liver cancer	0.0144	0.166	CbGeAlD
Hydroxocobalamin—MMACHC—liver—liver cancer	0.0096	0.111	CbGeAlD
Hydroxocobalamin—Folliculitis—Sorafenib—liver cancer	0.00834	0.0323	CcSEcCtD
Hydroxocobalamin—AMN—liver—liver cancer	0.0079	0.0911	CbGeAlD
Hydroxocobalamin—Pleural effusion—Sorafenib—liver cancer	0.00684	0.0265	CcSEcCtD
Hydroxocobalamin—MMAA—liver—liver cancer	0.00629	0.0725	CbGeAlD
Hydroxocobalamin—MMAB—liver—liver cancer	0.0059	0.068	CbGeAlD
Hydroxocobalamin—CASP9—liver—liver cancer	0.00551	0.0635	CbGeAlD
Hydroxocobalamin—Sensitisation—Epirubicin—liver cancer	0.00542	0.021	CcSEcCtD
Hydroxocobalamin—TCN2—liver—liver cancer	0.00538	0.062	CbGeAlD
Hydroxocobalamin—Blood pressure increased—Sorafenib—liver cancer	0.00524	0.0203	CcSEcCtD
Hydroxocobalamin—Sensitisation—Doxorubicin—liver cancer	0.00502	0.0194	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Epirubicin—liver cancer	0.0049	0.019	CcSEcCtD
Hydroxocobalamin—Haematochezia—Epirubicin—liver cancer	0.00481	0.0186	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Doxorubicin—liver cancer	0.00453	0.0176	CcSEcCtD
Hydroxocobalamin—Haematochezia—Doxorubicin—liver cancer	0.00445	0.0172	CcSEcCtD
Hydroxocobalamin—Eczema—Sorafenib—liver cancer	0.00423	0.0164	CcSEcCtD
Hydroxocobalamin—MUT—liver—liver cancer	0.00423	0.0487	CbGeAlD
Hydroxocobalamin—Cardiac failure congestive—Sorafenib—liver cancer	0.0042	0.0163	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Sorafenib—liver cancer	0.00382	0.0148	CcSEcCtD
Hydroxocobalamin—MTRR—liver—liver cancer	0.0038	0.0438	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Epirubicin—liver cancer	0.00359	0.0139	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Sorafenib—liver cancer	0.00346	0.0134	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—liver cancer	0.00332	0.0129	CcSEcCtD
Hydroxocobalamin—MTR—liver—liver cancer	0.00332	0.0382	CbGeAlD
Hydroxocobalamin—Dysphagia—Sorafenib—liver cancer	0.00329	0.0127	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Sorafenib—liver cancer	0.00315	0.0122	CcSEcCtD
Hydroxocobalamin—Folliculitis—Epirubicin—liver cancer	0.00308	0.0119	CcSEcCtD
Hydroxocobalamin—Redness—Epirubicin—liver cancer	0.00287	0.0111	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—liver cancer	0.00285	0.0111	CcSEcCtD
Hydroxocobalamin—Lung disorder—Epirubicin—liver cancer	0.00274	0.0106	CcSEcCtD
Hydroxocobalamin—Thrombosis—Epirubicin—liver cancer	0.00274	0.0106	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—liver cancer	0.00265	0.0103	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Sorafenib—liver cancer	0.0026	0.0101	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Sorafenib—liver cancer	0.00258	0.01	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—liver cancer	0.00253	0.00981	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—liver cancer	0.00253	0.00981	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Epirubicin—liver cancer	0.00253	0.0098	CcSEcCtD
Hydroxocobalamin—Feeling hot—Epirubicin—liver cancer	0.00247	0.00956	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Sorafenib—liver cancer	0.00244	0.00947	CcSEcCtD
Hydroxocobalamin—Angiopathy—Sorafenib—liver cancer	0.00239	0.00925	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Sorafenib—liver cancer	0.00238	0.00921	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Sorafenib—liver cancer	0.00237	0.00919	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Sorafenib—liver cancer	0.00235	0.00911	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—liver cancer	0.00234	0.00907	CcSEcCtD
Hydroxocobalamin—Mental disorder—Sorafenib—liver cancer	0.00231	0.00894	CcSEcCtD
Hydroxocobalamin—Erythema—Sorafenib—liver cancer	0.00229	0.00888	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—liver cancer	0.00228	0.00885	CcSEcCtD
Hydroxocobalamin—Extravasation—Epirubicin—liver cancer	0.00222	0.0086	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Epirubicin—liver cancer	0.00214	0.00831	CcSEcCtD
Hydroxocobalamin—Angioedema—Sorafenib—liver cancer	0.00209	0.00811	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—liver cancer	0.00205	0.00796	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00198	0.00769	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00194	0.00751	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—liver cancer	0.00193	0.00746	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Sorafenib—liver cancer	0.00187	0.00725	CcSEcCtD
Hydroxocobalamin—Infection—Sorafenib—liver cancer	0.00186	0.0072	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Sorafenib—liver cancer	0.00183	0.00711	CcSEcCtD
Hydroxocobalamin—Skin disorder—Sorafenib—liver cancer	0.00182	0.00704	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—liver cancer	0.00178	0.0069	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—liver cancer	0.00172	0.00668	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Sorafenib—liver cancer	0.00167	0.00646	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Sorafenib—liver cancer	0.00165	0.00638	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—liver cancer	0.00163	0.00633	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00161	0.00626	CcSEcCtD
Hydroxocobalamin—Pain—Sorafenib—liver cancer	0.0016	0.0062	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—liver cancer	0.0016	0.00618	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—liver cancer	0.00156	0.00606	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—liver cancer	0.00155	0.00601	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—liver cancer	0.00151	0.00585	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—liver cancer	0.0015	0.00583	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—liver cancer	0.00149	0.00577	CcSEcCtD
Hydroxocobalamin—Urticaria—Sorafenib—liver cancer	0.00149	0.00576	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Sorafenib—liver cancer	0.00148	0.00573	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—liver cancer	0.00147	0.0057	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—liver cancer	0.00145	0.00561	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—liver cancer	0.00143	0.00556	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—liver cancer	0.00141	0.00547	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—liver cancer	0.00139	0.00539	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—liver cancer	0.00138	0.00534	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sorafenib—liver cancer	0.00138	0.00534	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—liver cancer	0.00136	0.00528	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—liver cancer	0.00134	0.00518	CcSEcCtD
Hydroxocobalamin—Pruritus—Sorafenib—liver cancer	0.00132	0.00513	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—liver cancer	0.00131	0.00506	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—liver cancer	0.00128	0.00496	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sorafenib—liver cancer	0.00128	0.00496	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—liver cancer	0.00124	0.00479	CcSEcCtD
Hydroxocobalamin—Dizziness—Sorafenib—liver cancer	0.00124	0.00479	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—liver cancer	0.00122	0.00471	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—liver cancer	0.00118	0.00459	CcSEcCtD
Hydroxocobalamin—Rash—Sorafenib—liver cancer	0.00118	0.00457	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sorafenib—liver cancer	0.00118	0.00457	CcSEcCtD
Hydroxocobalamin—Headache—Sorafenib—liver cancer	0.00117	0.00454	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—liver cancer	0.00112	0.00436	CcSEcCtD
Hydroxocobalamin—Nausea—Sorafenib—liver cancer	0.00111	0.0043	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—liver cancer	0.000961	0.00372	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—liver cancer	0.000958	0.00371	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—liver cancer	0.000953	0.0037	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—liver cancer	0.000909	0.00352	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—liver cancer	0.000903	0.0035	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—liver cancer	0.000889	0.00344	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—liver cancer	0.000887	0.00344	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—liver cancer	0.000882	0.00342	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—liver cancer	0.000882	0.00342	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—liver cancer	0.000879	0.0034	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—liver cancer	0.000877	0.0034	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—liver cancer	0.000873	0.00338	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—liver cancer	0.000869	0.00337	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—liver cancer	0.000852	0.0033	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—liver cancer	0.000847	0.00328	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—liver cancer	0.000841	0.00326	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—liver cancer	0.000835	0.00324	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—liver cancer	0.000817	0.00316	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—liver cancer	0.000813	0.00315	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—liver cancer	0.000811	0.00314	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—liver cancer	0.000808	0.00313	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—liver cancer	0.000804	0.00312	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—liver cancer	0.000788	0.00306	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—liver cancer	0.000786	0.00304	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—liver cancer	0.000783	0.00304	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—liver cancer	0.000778	0.00302	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—liver cancer	0.000764	0.00296	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—liver cancer	0.000727	0.00282	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—liver cancer	0.000721	0.00279	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—liver cancer	0.00072	0.00279	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000716	0.00277	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—liver cancer	0.000712	0.00276	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—liver cancer	0.000707	0.00274	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—liver cancer	0.000691	0.00268	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—liver cancer	0.000691	0.00268	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—liver cancer	0.000687	0.00266	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—liver cancer	0.000678	0.00263	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—liver cancer	0.000674	0.00261	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—liver cancer	0.000671	0.0026	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—liver cancer	0.000667	0.00259	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000662	0.00257	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—liver cancer	0.000659	0.00255	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—liver cancer	0.000639	0.00248	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—liver cancer	0.000639	0.00248	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—liver cancer	0.000635	0.00246	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—liver cancer	0.000627	0.00243	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—liver cancer	0.000624	0.00242	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—liver cancer	0.000621	0.00241	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—liver cancer	0.000616	0.00239	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—liver cancer	0.000608	0.00236	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000597	0.00231	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—liver cancer	0.000591	0.00229	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—liver cancer	0.00057	0.00221	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—liver cancer	0.000569	0.00221	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—liver cancer	0.000563	0.00218	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000552	0.00214	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—liver cancer	0.000549	0.00213	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—liver cancer	0.000547	0.00212	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—liver cancer	0.000546	0.00212	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—liver cancer	0.000527	0.00204	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—liver cancer	0.000509	0.00197	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—liver cancer	0.000508	0.00197	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—liver cancer	0.000505	0.00196	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—liver cancer	0.000489	0.00189	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—liver cancer	0.000473	0.00183	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—liver cancer	0.000471	0.00183	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—liver cancer	0.000457	0.00177	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—liver cancer	0.000452	0.00175	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—liver cancer	0.000437	0.0017	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—liver cancer	0.000436	0.00169	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—liver cancer	0.000435	0.00169	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—liver cancer	0.000433	0.00168	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—liver cancer	0.000423	0.00164	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—liver cancer	0.00041	0.00159	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—liver cancer	0.000403	0.00156	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—liver cancer	0.000403	0.00156	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—liver cancer	0.000401	0.00155	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—liver cancer	0.00038	0.00147	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—MTOR—liver cancer	9.38e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CB—liver cancer	9.38e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—liver cancer	9.32e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PRKCE—liver cancer	9.28e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTM1—liver cancer	9.24e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—STAT3—liver cancer	9.23e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—liver cancer	9.23e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—liver cancer	9.23e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CDKN1A—liver cancer	9.22e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CDKN1A—liver cancer	9.22e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—liver cancer	9.21e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—liver cancer	9.21e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CD—liver cancer	9.01e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—liver cancer	9.01e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RAF1—liver cancer	9e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HGF—liver cancer	9e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADAM17—liver cancer	8.92e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CB—liver cancer	8.92e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CB—liver cancer	8.92e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—liver cancer	8.89e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CSF2—liver cancer	8.89e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ALB—liver cancer	8.89e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CD—liver cancer	8.83e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1B—liver cancer	8.8e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CDKN1A—liver cancer	8.8e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MTOR—liver cancer	8.79e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CB—liver cancer	8.79e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP1A1—liver cancer	8.76e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SERPINE1—liver cancer	8.74e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—liver cancer	8.69e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RAF1—liver cancer	8.64e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—liver cancer	8.58e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—liver cancer	8.57e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—liver cancer	8.56e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—liver cancer	8.53e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—liver cancer	8.53e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CB—liver cancer	8.51e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MTOR—liver cancer	8.44e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CB—liver cancer	8.44e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CG—liver cancer	8.42e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSMA4—liver cancer	8.39e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSMD10—liver cancer	8.39e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—liver cancer	8.32e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—liver cancer	8.31e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1B—liver cancer	8.25e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—liver cancer	8.23e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—liver cancer	8.23e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APC—liver cancer	8.19e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—liver cancer	8.17e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—liver cancer	8.12e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1A—liver cancer	8.12e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—H2AFX—liver cancer	8.09e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARA—liver cancer	8.01e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—liver cancer	7.93e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—liver cancer	7.93e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1B—liver cancer	7.92e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RAF1—liver cancer	7.89e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CB—liver cancer	7.85e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—liver cancer	7.85e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—JUN—liver cancer	7.85e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—liver cancer	7.84e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—liver cancer	7.84e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—liver cancer	7.79e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTOR—liver cancer	7.7e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CB—liver cancer	7.7e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—liver cancer	7.7e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—liver cancer	7.67e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—liver cancer	7.65e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—liver cancer	7.65e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—liver cancer	7.63e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—liver cancer	7.63e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1A—liver cancer	7.61e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2L1—liver cancer	7.61e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—liver cancer	7.59e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK8—liver cancer	7.43e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CD—liver cancer	7.4e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—liver cancer	7.34e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—liver cancer	7.32e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1A—liver cancer	7.31e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ALB—liver cancer	7.3e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—liver cancer	7.3e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—liver cancer	7.28e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—liver cancer	7.28e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—liver cancer	7.25e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—liver cancer	7.25e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—liver cancer	7.25e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—liver cancer	7.23e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK14—liver cancer	7.2e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—liver cancer	7.2e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—liver cancer	7.17e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SERPINE1—liver cancer	7.12e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—liver cancer	7.07e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—liver cancer	7.07e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—liver cancer	7e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—liver cancer	6.94e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—liver cancer	6.94e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—liver cancer	6.86e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—liver cancer	6.83e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—liver cancer	6.74e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—liver cancer	6.74e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—liver cancer	6.73e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—liver cancer	6.72e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—liver cancer	6.67e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—liver cancer	6.62e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—liver cancer	6.56e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—liver cancer	6.56e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCE—liver cancer	6.5e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—liver cancer	6.49e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—liver cancer	6.49e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—liver cancer	6.45e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—liver cancer	6.45e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAF1—liver cancer	6.43e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—liver cancer	6.4e-05	9.99e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—liver cancer	6.4e-05	9.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—liver cancer	6.28e-05	9.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—liver cancer	6.28e-05	9.8e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—liver cancer	6.22e-05	9.71e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—liver cancer	6.19e-05	9.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—liver cancer	6.17e-05	9.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF2—liver cancer	6.16e-05	9.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—liver cancer	6.15e-05	9.6e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—liver cancer	6.1e-05	9.52e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—liver cancer	6.03e-05	9.41e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—liver cancer	6.01e-05	9.38e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—liver cancer	6.01e-05	9.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—liver cancer	5.95e-05	9.29e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—liver cancer	5.95e-05	9.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—liver cancer	5.95e-05	9.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—liver cancer	5.89e-05	9.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—liver cancer	5.87e-05	9.17e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—liver cancer	5.86e-05	9.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—liver cancer	5.83e-05	9.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—liver cancer	5.8e-05	9.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CSF2—liver cancer	5.75e-05	8.98e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—liver cancer	5.75e-05	8.97e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—liver cancer	5.75e-05	8.97e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—liver cancer	5.73e-05	8.94e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—liver cancer	5.72e-05	8.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—H2AFX—liver cancer	5.67e-05	8.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—liver cancer	5.6e-05	8.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—liver cancer	5.56e-05	8.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—liver cancer	5.53e-05	8.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—liver cancer	5.52e-05	8.61e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—liver cancer	5.48e-05	8.56e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—liver cancer	5.44e-05	8.49e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—liver cancer	5.44e-05	8.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—liver cancer	5.44e-05	8.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—liver cancer	5.42e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—liver cancer	5.36e-05	8.37e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—liver cancer	5.36e-05	8.37e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—liver cancer	5.36e-05	8.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—liver cancer	5.36e-05	8.36e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—liver cancer	5.3e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—liver cancer	5.3e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—liver cancer	5.29e-05	8.25e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—liver cancer	5.26e-05	8.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAF1—liver cancer	5.24e-05	8.18e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—liver cancer	5.19e-05	8.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—liver cancer	5.14e-05	8.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—liver cancer	5.13e-05	8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—liver cancer	5.12e-05	7.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—liver cancer	5.12e-05	7.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—liver cancer	5.11e-05	7.97e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—liver cancer	5.06e-05	7.9e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—liver cancer	5.06e-05	7.9e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—liver cancer	4.98e-05	7.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—liver cancer	4.96e-05	7.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—liver cancer	4.85e-05	7.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAF1—liver cancer	4.84e-05	7.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—liver cancer	4.8e-05	7.5e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—liver cancer	4.79e-05	7.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—liver cancer	4.76e-05	7.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—liver cancer	4.74e-05	7.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—liver cancer	4.73e-05	7.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—liver cancer	4.73e-05	7.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—liver cancer	4.7e-05	7.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—liver cancer	4.69e-05	7.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—liver cancer	4.69e-05	7.32e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—liver cancer	4.67e-05	7.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK14—liver cancer	4.66e-05	7.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—liver cancer	4.57e-05	7.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—liver cancer	4.57e-05	7.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—liver cancer	4.54e-05	7.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—F2—liver cancer	4.51e-05	7.04e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—liver cancer	4.51e-05	7.04e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—liver cancer	4.5e-05	7.02e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—liver cancer	4.44e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—liver cancer	4.44e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—liver cancer	4.43e-05	6.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—liver cancer	4.43e-05	6.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—liver cancer	4.38e-05	6.83e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—liver cancer	4.34e-05	6.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK8—liver cancer	4.33e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—liver cancer	4.32e-05	6.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—liver cancer	4.32e-05	6.74e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—liver cancer	4.24e-05	6.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—liver cancer	4.2e-05	6.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—liver cancer	4.19e-05	6.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—liver cancer	4.16e-05	6.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—liver cancer	4.16e-05	6.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—liver cancer	4.09e-05	6.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—liver cancer	4.06e-05	6.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—liver cancer	3.96e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—liver cancer	3.93e-05	6.14e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—liver cancer	3.91e-05	6.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—liver cancer	3.83e-05	5.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—liver cancer	3.83e-05	5.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—liver cancer	3.8e-05	5.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—liver cancer	3.76e-05	5.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—liver cancer	3.65e-05	5.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—liver cancer	3.54e-05	5.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—liver cancer	3.4e-05	5.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—liver cancer	3.39e-05	5.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAF1—liver cancer	3.39e-05	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—liver cancer	3.39e-05	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—liver cancer	3.39e-05	5.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—liver cancer	3.31e-05	5.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—liver cancer	3.31e-05	5.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—liver cancer	3.21e-05	5.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—liver cancer	3.2e-05	5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—liver cancer	3.14e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—liver cancer	3.13e-05	4.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—liver cancer	3.12e-05	4.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—liver cancer	3.11e-05	4.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—liver cancer	3.04e-05	4.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—liver cancer	3.04e-05	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—liver cancer	2.96e-05	4.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—liver cancer	2.96e-05	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—liver cancer	2.93e-05	4.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—liver cancer	2.89e-05	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—liver cancer	2.88e-05	4.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—liver cancer	2.88e-05	4.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—liver cancer	2.87e-05	4.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK8—liver cancer	2.8e-05	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—liver cancer	2.76e-05	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—liver cancer	2.67e-05	4.16e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—liver cancer	2.62e-05	4.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—liver cancer	2.58e-05	4.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—liver cancer	2.56e-05	3.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—liver cancer	2.55e-05	3.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—liver cancer	2.55e-05	3.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—liver cancer	2.38e-05	3.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—liver cancer	2.37e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—liver cancer	2.35e-05	3.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—liver cancer	2.2e-05	3.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—liver cancer	2.02e-05	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—liver cancer	1.95e-05	3.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—liver cancer	1.87e-05	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—liver cancer	1.79e-05	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—liver cancer	1.65e-05	2.57e-05	CbGpPWpGaD
